5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Switching to the cyclic pentose phosphate pathway powers the oxidative burst in activated neutrophils

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Neutrophils are cells at the frontline of innate immunity that can quickly activate effector functions to eliminate pathogens upon stimulation. However, little is known about the metabolic adaptations that power these functions. Here we show rapid metabolic alterations in neutrophils upon activation, particularly drastic reconfiguration around the pentose phosphate pathway, which is specifically and quantitatively coupled to an oxidative burst. During this oxidative burst, neutrophils switch from glycolysis-dominant metabolism to a unique metabolic mode termed ‘pentose cycle’, where all glucose-6-phosphate is diverted into oxidative pentose phosphate pathway and net flux through upper glycolysis is reversed to allow substantial recycling of pentose phosphates. This reconfiguration maximizes NADPH yield to fuel superoxide production via NADPH oxidase. Disruptions of pentose cycle greatly suppress oxidative burst, the release of neutrophil extracellular traps and pathogen killing by neutrophils. Together, these results demonstrate the remarkable metabolic flexibility of neutrophils, which is essential for their functions as the first responders in innate immunity.

          Abstract

          Upon activation, neutrophils undergo rapid metabolic reconfigurations towards pentose cycling, which powers their effector functions.

          Related collections

          Most cited references72

          • Record: found
          • Abstract: found
          • Article: not found

          Neutrophil extracellular traps kill bacteria.

          Neutrophils engulf and kill bacteria when their antimicrobial granules fuse with the phagosome. Here, we describe that, upon activation, neutrophils release granule proteins and chromatin that together form extracellular fibers that bind Gram-positive and -negative bacteria. These neutrophil extracellular traps (NETs) degrade virulence factors and kill bacteria. NETs are abundant in vivo in experimental dysentery and spontaneous human appendicitis, two examples of acute inflammation. NETs appear to be a form of innate response that binds microorganisms, prevents them from spreading, and ensures a high local concentration of antimicrobial agents to degrade virulence factors and kill bacteria.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            A guide to immunometabolism for immunologists.

            In recent years a substantial number of findings have been made in the area of immunometabolism, by which we mean the changes in intracellular metabolic pathways in immune cells that alter their function. Here, we provide a brief refresher course on six of the major metabolic pathways involved (specifically, glycolysis, the tricarboxylic acid (TCA) cycle, the pentose phosphate pathway, fatty acid oxidation, fatty acid synthesis and amino acid metabolism), giving specific examples of how precise changes in the metabolites of these pathways shape the immune cell response. What is emerging is a complex interplay between metabolic reprogramming and immunity, which is providing an extra dimension to our understanding of the immune system in health and disease.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found

              Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism

              Tumor maintenance relies on continued activity of driver oncogenes, although their rate-limiting role is highly context dependent. Oncogenic Kras mutation is the signature event in pancreatic ductal adenocarcinoma (PDAC), serving a critical role in tumor initiation. Here, an inducible Kras(G12D)-driven PDAC mouse model establishes that advanced PDAC remains strictly dependent on Kras(G12D) expression. Transcriptome and metabolomic analyses indicate that Kras(G12D) serves a vital role in controlling tumor metabolism through stimulation of glucose uptake and channeling of glucose intermediates into the hexosamine biosynthesis and pentose phosphate pathways (PPP). These studies also reveal that oncogenic Kras promotes ribose biogenesis. Unlike canonical models, we demonstrate that Kras(G12D) drives glycolysis intermediates into the nonoxidative PPP, thereby decoupling ribose biogenesis from NADP/NADPH-mediated redox control. Together, this work provides in vivo mechanistic insights into how oncogenic Kras promotes metabolic reprogramming in native tumors and illuminates potential metabolic targets that can be exploited for therapeutic benefit in PDAC. Copyright © 2012 Elsevier Inc. All rights reserved.
                Bookmark

                Author and article information

                Contributors
                jfan@morgridge.org
                Journal
                Nat Metab
                Nat Metab
                Nature Metabolism
                Nature Publishing Group UK (London )
                2522-5812
                28 March 2022
                28 March 2022
                2022
                : 4
                : 3
                : 389-403
                Affiliations
                [1 ]GRID grid.509573.d, ISNI 0000 0004 0405 0937, Morgridge Institute for Research, ; Madison, WI USA
                [2 ]GRID grid.14003.36, ISNI 0000 0001 2167 3675, Department of Nutritional Sciences, , University of Wisconsin-Madison, ; Madison, WI USA
                [3 ]GRID grid.14003.36, ISNI 0000 0001 2167 3675, Cell and Molecular Biology Graduate Program, , University of Wisconsin-Madison, ; Madison, WI USA
                [4 ]GRID grid.14003.36, ISNI 0000 0001 2167 3675, Department of Medical Microbiology and Immunology, , University of Wisconsin-Madison, ; Madison, WI USA
                [5 ]GRID grid.14003.36, ISNI 0000 0001 2167 3675, Comparative Biomedical Sciences Graduate Program, , University of Wisconsin-Madison, ; Madison, WI USA
                [6 ]GRID grid.2515.3, ISNI 0000 0004 0378 8438, Division of Immunology, , Boston Children’s Hospital, Harvard Medical School, ; Boston, MA USA
                [7 ]GRID grid.14003.36, ISNI 0000 0001 2167 3675, Department of Pediatrics, , University of Wisconsin-Madison, ; Madison, WI USA
                Author information
                http://orcid.org/0000-0002-6177-139X
                http://orcid.org/0000-0003-4563-7569
                http://orcid.org/0000-0002-2955-7385
                http://orcid.org/0000-0002-5326-5358
                Article
                550
                10.1038/s42255-022-00550-8
                8964420
                35347316
                a5070424-b209-497e-95f4-c44d8b648445
                © The Author(s) 2022

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 16 January 2021
                : 11 February 2022
                Funding
                Funded by: FundRef https://doi.org/10.13039/100000009, Foundation for the National Institutes of Health (Foundation for the National Institutes of Health, Inc.);
                Award ID: F31AI152280
                Award ID: R35GM118027
                Award ID: R56AI158958
                Award Recipient :
                Categories
                Article
                Custom metadata
                © The Author(s), under exclusive licence to Springer Nature Limited 2022

                metabolomics,innate immune cells,metabolism
                metabolomics, innate immune cells, metabolism

                Comments

                Comment on this article